Skip to main content

Table 1 Characteristics of the studies eligible for current meta-analysis

From: No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-α gene and susceptibility to prostate cancer: a comprehensive meta-analysis

AuthorYearCountryEthnicityCaseControlSOCCasesControlsHWEGenotype
MMMWWWMMMWWW
rs1800629
 Jones2013USAAfrican-American279535HB5103171141533680.687Illumina’s Golden gate
 Zabaleta2008USAAfrican-American67130HB2956333940.958Sequence
 Berhane2012IndiaAsian150150HB6241201181310.662ARMS-PCR
 Wu2003China-TaiwanAsian96126HB220741221030.882PCR-RFLP
 Alidoost2019IranAsian100110HB01684014960.476PCR-RFLP/ARMS-PCR
 Kesarwani2009IndiaAsian197256HB1211754372150.115PCR-RFLP
 Ali2019IraqAsian3030PB1218024600.543PCR-RFLP
 Ge2007ChinaAsian245245HB2392042481950.609TaqMan
 Dluzniewski2012USACaucasian468468HB1411334161263360.125MassArray
 Pardo2019VenezuelaCaucasian4040HB0634011290.313PCR-RFLP
 Zabaleta2008USACaucasian479400HB9148322101182720.505Sequence
 Sáenz-López2008SpainCaucasian296310PB5702212522560.714TaqMan
 Moore2009USACaucasian949857PB21228700112056410.231TaqMan
 Danforth2008USACaucasian11551380PB26336793454189260.795TaqMan/MGBEclipse assay
 Danforth2008USACaucasian11111125PB25294792332868060.217TaqMan/MGBEclipse assay
 Ribeiro2012PortugalCaucasian449557PB811532671434070.155TaqMan
 Wang2009USACaucasian251250PB12791609691720.529TaqMan
 Bandil2017IndiaAsian105115HB9158147104< 0.001ARMS-PCR
 Omrani2008IranAsian41105HB03653993< 0.001ASO-PCR
 McCarron2002United KingdomCaucasian239220HB66616713571500.023ARMS-PCR
 OH2000USACaucasian7373HB0532005320< 0.001allele-specific PCR
 Zhang2010USACaucasian116128PB  116  128 CBMALD-TOF-MS
rs361525
 Pardo2019VenezuelaCaucasian4040HB043601390.936PCR-RFLP
 OH2000USACaucasian7373HB02350023500.11allele-specific PCR
 Zabaleta2008USACaucasian471385HB6414240393460.295Sequence
 Alidoost2019IranAsian100110HB01090051050.807PCR-RFLP/ARMS-PCR
 Danforth2008USACaucasian11141126PB1121992310010230.737TaqMan/MGBEclipse assay
 Ge2007ChinaAsian245245HB0102350222230.461TaqMan
 Zabaleta2008USAAfrican-American64126HB06582101140.006Sequence
 Bandil2017IndiaAsian105115HB12603320869< 0.001ARMS-PCR
rs1799724
 Danforth2008USACaucasian11391378PB132039231425411100.9TaqMan/MGBEclipse assay
 Danforth2008USACaucasian11081101PB17183908192208620.257TaqMan/MGBEclipse assay
 Kesarwani2009IndiaAsian197256HB4571364561961PCR-RFLP
 Zabaleta2008USAAfrican-American464372HB659399841323< 0.001Sequence
 Zabaleta2008USACaucasian614HB303707< 0.001Sequence
rs1799964
 Danforth2008USACaucasian11421375PB60361721584418760.791TaqMan/MGBEclipse assay
 Danforth2008USACaucasian11431155PB54370719643777140.129TaqMan/MGBEclipse assay
 Kesarwani2009IndiaAsian197256HB906443839182< 0.001PCR-RFLP
  1. HB hospital-based, PB population-based, SOC source of control, PCR-FLIP polymerase chain reaction and restrictive fragment length polymorphism; ARMS amplification refractory mutation system, HWE Hardy–Weinberg equilibrium of control group, W wild type-allele, M mutant-allele